The Next Phase: Exploring Innovation in Clinical Trials Underrepresentation in Clinical Trials
Aug 12, 2022
28:09
You wouldn’t take a drug if you didn’t know if it was going to help you.
It might surprise you to hear millions of people do this every day. Not because they don’t care or don’t want to know, but because they live in a system that wasn’t built for them.
This is the reality for underrepresented communities and racial and ethnic minorities who have been all-but-locked-out of the clinical trial process.
Tiffany Whitlow, Co-Founder & Chief Development Officer at Acclinate, shares her insights about the depth of inequity in the clinical trials system and how we can fix it.
Join us as we discuss:
How Tiffany co-founded a company made to bring DEI back into clinical trials
The surprising statistics surrounding inequity in healthcare
How Acclinate is changing the system to bring clinical trials to those who need them most
What pharmaceutical sponsors and research sites need to do to increase clinical trial equity
It might surprise you to hear millions of people do this every day. Not because they don’t care or don’t want to know, but because they live in a system that wasn’t built for them.
This is the reality for underrepresented communities and racial and ethnic minorities who have been all-but-locked-out of the clinical trial process.
Tiffany Whitlow, Co-Founder & Chief Development Officer at Acclinate, shares her insights about the depth of inequity in the clinical trials system and how we can fix it.
Join us as we discuss:
How Tiffany co-founded a company made to bring DEI back into clinical trials
The surprising statistics surrounding inequity in healthcare
How Acclinate is changing the system to bring clinical trials to those who need them most
What pharmaceutical sponsors and research sites need to do to increase clinical trial equity